ArticleJournal of pharmacy & bioallied sciences2025
A Comparative Study of Complications Related to Chemoport and Peripheral Line Among Cancer Patients Receiving Chemotherapy in Teaching Hospitals.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Most patients with cancer under chemotherapy need reliable access into the veins for drugs, and this can be established via peripheral lines or chemoports. However, the complications that arise in one method differ from another method. This study seeks to compare complications between chemoport and peripheral lines in the hospital teaching setup of cancer patients treated with chemotherapy. Methods: The survey conducted was a comparative observational one, involving 80 cancer patients, out of whom 40 used peripheral lines and 40 chemoports. An observational checklist was used to gather data regarding the complications and their severity during the chemotherapy sessions. The complications under observation were infections, extravasations, and phlebitis, concerning the impact of demographic and clinical variables on the complication rates. Results: More complications were reported among patients with peripheral lines, including pain, extravasations, and phlebitis; meanwhile, fewer major complications occurred in chemoports. T-values, in comparisons of complications among chemoport and peripheral lines, proved to be statistically significant in terms of being more common and severe. The other demographic factors of age and gender were found not to have a statistically significant correlation with the kind of complications. Conclusion: They end up causing more complications compared to chemoports in the long-term, yet at first view seem less invasive than peripheral lines. Chemoports result in fewer severe complications and are hence preferable for the long-term administration of chemotherapy in cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.